Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001520138-26-000439·FIDELION DIAGNOSTICS PTE. LTD.
Schedule 13G ownership disclosure
BIONEXUS GENE LAB CORP
COMMON STOCK, NO PAR VALUE · CUSIP: 090628306
Event date: 2025-11-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Fidelion Diagnostics Pte. Ltd.
Shares: 392,329.00 · Class: 13.4%
- MOLECULE BIO LLC
Shares: 392,329.00 · Class: 13.4%
- XIAO LING
Shares: 392,329.00 · Class: 13.4%
- RAINY MORNING TECHNOLOGY (HONG KONG) LIMITED
Shares: 392,329.00 · Class: 13.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001520138-26-000439
- Form type
- SCHEDULE 13G
- Filer
- FIDELION DIAGNOSTICS PTE. LTD.
- CIK
- CIK 2104953
- Filed
- Oct 22, 2026
- Reporting period
- Nov 28, 2025
- Description
- Schedule 13G beneficial ownership